Your browser doesn't support javascript.
loading
Successful neoadjuvant treatment of EGFR exon 19 deletion combined with TP53 mutation in non-small cell lung cancer using aumolertinib after osimertinib-induced myocardial damage: a case report and literature review.
Zhang, Guijuan; Tang, Xiaoyuan; Zhang, Xingping; Qiu, Xingting; Lai, Qingwen; Li, Jie.
Afiliação
  • Zhang G; Department of Respiratory and Critical Care, First Affiliated Hospital of Gannan Medical University.
  • Tang X; Department of Respiratory and Critical Care, First Affiliated Hospital of Gannan Medical University.
  • Zhang X; Cyberspace Institute of Advanced Technology, Guangzhou University.
  • Qiu X; Department of Radiology, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
  • Lai Q; Department of Respiratory and Critical Care, First Affiliated Hospital of Gannan Medical University.
  • Li J; Department of Respiratory and Critical Care, First Affiliated Hospital of Gannan Medical University.
Anticancer Drugs ; 34(8): 954-961, 2023 09 01.
Article em En | MEDLINE | ID: mdl-36800249
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article